This framework agreement is for the supply of medicines under the CANAMED program. The quantities related to this agreement are detailed in section "II.2 List of Lots". Subsequent contracts will typically be awarded on a semi-annual basis, but may also be concluded monthly or quarterly depending on
Contract awarded. Originally published 12 months ago.
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.